Dose-response effects of a new growth hormone receptor antagonist (B2036-PEG) on circulating, hepatic and renal expression of the growth hormone/insulin-like growth factor system in adult mice

Journal of Endocrinology

Volumn 167, Issue 2, 2000, Pages 295-303

  Van Neck, J W ^a   Dits, N F J ^a   Cingel, V ^a   Hoppenbrouwers, I A ^a   Drop, S L S ^a   Flyvbjerg, A ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE RECEPTOR ANTAGONIST; HORMONE RECEPTOR BLOCKING AGENT; PEGVISOMANT; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HORMONE RELEASE; KIDNEY; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEPTOR BLOCKING;

EID: 0033769532     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1670295     Document Type: Article

References (34)

1. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily
2. Serum levels of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 reflect spontaneous growth hormone secretion
3. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I
4. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice
5. A growth hormone antagonist protects mice against streptozotocin induced glomerulosclerosis even in the presence of elevated levels of glucose and glycated hemoglobin
6. Liver and kidney growth hormone (GH) receptors are regulated differently in diabetic GH and GH antagonist transgenic mice
7. Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice
8. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice
9. Mutations in the third alpha-helix of bovine growth hormone dramatically affect its intracellular distribution in vitro and growth enhancement in transgenic mice
10. Glycine 119 of bovine growth hormone is critical for growth-promoting activity
11. In vitro and in vivo studies of the antagonistic effects of human growth hormone analogs
12. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
13. Genomic sequencing
14. Long-acting growth hormones produced by conjugation with polyethylene glycol
15. Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum
16. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism
17. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action
18. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats
19. Octreotide administration in diabetic rats: Effects on renal hypertrophy and urinary albumin excretion
20. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice
21. Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent
22. Rational design of potent antagonists to the human growth hormone receptor
23. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: Effects of IGF-I therapy on IGFBP-3
24. Analysis of serum insulin-like growth factor binding proteins using western blotting: Use of the method for titration of the binding proteins and competitive binding studies
25. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
26. Growth hormone and nutrition interact to regulate expressions of kidney IGF-I and IGFBP mRNAs
27. Regulation of rat growth hormone receptor gene expression
28. Insulin-like growth factor-I action on growth hormone secretion and messenger ribonucleic acid levels: Interaction with somatostatin
29. cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins
30. Growth hormone receptor antagonism prevents early renal changes in nonobese diabetic mice
31. Growth hormone (GH) receptors, binding proteins and IGF-I concentrations in the serum of transgenic mice expressing bovine GH agonist or antagonist
32. Regulation of immunoreactive growth hormone secretion in male rats
33. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
34. Binding and action of insulin-like growth factor-I in pituitary tumor cells